InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Perkins Adelene Q, Directeur. Director active across 2 companies, notably BRUKER CORP. Aggregated, 6 disclosures have been logged. Activity tracked since 5 January 2022. The latest transaction was disclosed on 15 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Perkins Adelene Q
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
4,520 股0Common StockSEC:0001375124-26-000002:0
3,298 股0Common StockSEC:0001415889-25-004650:0
2,377 股0Common StockSEC:0001415889-24-000848:0
768,133 股Common StockSEC:0000899243-23-018762:0
1,970 股0Common StockSEC:0001415889-23-000675:0
1,841 股0Common StockSEC:0001179110-22-000300:0
6 条申报中的 6 条
About Perkins Adelene Q
Perkins Adelene Q is Director at BRUKER CORP and Infinity Pharmaceuticals, INC. The record shows 6 filings in total, with recent filings between 2022-01-06 and 2026-02-18. The sampled filings indicate an attribution-type transaction nature, with buy and sell amounts at EUR 0.
